HDBuzz summarises all the science from the 2017 Huntington's Disease Therapeutics Conference in Malta - day 1
Two recent studies show how a cellular border control system goes wrong in HD, opening new avenues for HD research.
Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease
Sheep can help us to identify HD biomarkers and recognize metabolic changes that occur before symptoms develop.
What can individual experiences with cannabis tell us about Huntington's disease?
Huntingtin helps fix damaged DNA, a recent study suggests, under the direction of a gene repair protein called ATM.
Is HD a developmental disease? HD stops neurons migrating in developing brain, but maybe we can get them going again
A new study provides the framework for finding factors that affect the onset and progression of HD
What if some problems in HD were due to something other than a harmful protein?
Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD
Work with genome editing techniques (zinc fingers and CRISPR) brings these tools closer to use in HD clinical trials